Skip to content

US · OPCH · MEDICAL - CARE FACILITIES

Option Care Health, Inc. (OPCH) intrinsic value and stock valuation

$31.59as of 2026-11-21 · Mkt cap 3.56B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Option Care Health, Inc. DCF and intrinsic value

InvestorsCraft values OPCH with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from OPCH’s statements →

Option Care Health, Inc. Graham Number

Graham Number: $15.35d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Bannockburn, IL 60015 optioncarehealth.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$5.65B+13.3% 5y CAGRd
20112025
Net income
$207.6M
20112025
Free cash flow
$217.1M+16.7% 5y CAGRd
20112025
Total equity
$1.33B+5.5% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$5.65B$5B$4.3B$3.94B$3.44B
Operating income$337.9M$321.8M$314.6M$240.2M$190.8M
Net income$207.6M$211.8M$267.1M$150.6M$139.9M
EPSd$1.27M$1.23M$1.48M$826.9K$772K
Operating cash flow$258.5M$323.4M$371.3M$267.6M$208.6M
Capital expenditure-$-41.31M-$-35.61M-$-41.87M-$-35.36M-$-25.63M
Free cash flow$217.1M$287.8M$329.4M$232.2M$182.9M
Total assets$3.46B$3.42B$3.33B$3.23B$2.93B
Total debt$1.27B$1.22B$1.17B$1.16B$1.16B
Net debt$1.04B$805.4M$822.6M$860.8M$1.04B
Total equity$1.33B$1.4B$1.42B$1.39B$1.18B
Cash and short-term investments$232.6M$412.6M$343.9M$294.2M$119.4M
Income statement
20252024202320222021
Revenue$5.65B$5B$4.3B$3.94B$3.44B
Cost of revenue$4.63B$3.99B$3.32B$3.08B$2.66B
Gross profit$1.02B$1.01B$981.2M$866.9M$779.6M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$682.5M$630.3M$607.4M$566.1M$525.7M
Other expenses$0.00$60.9M$59.2M$60.6M$63.1M
Operating expenses$682.5M$691.2M$666.6M$626.7M$588.8M
Cost and expenses$5.31B$4.68B$3.99B$3.7B$3.25B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$63.2M$60.6M$62.2M$54.9M$55.5M
Depreciation and amortization$70.7M$63.5M$62.2M$65.4M$68.8M
Ebitda$416.8M$396.1M$472.2M$325M$252.3M
Operating income$337.9M$321.8M$314.6M$240.2M$190.8M
Total other income/expenses, net-$-55.01M-$-38.23M$44.2M-$-34.46M-$-74.35M
Income before tax$282.9M$283.6M$358.7M$205.8M$116.5M
Income tax expense$75.3M$71.8M$91.7M$55.2M-$-23.4M
Net income$207.6M$211.8M$267.1M$150.6M$139.9M
Weighted average shares outstanding$162.1M$171.6M$179M$181.1M$179.9M
Weighted average diluted shares outstanding$163.4M$172.8M$180.4M$182.1M$181.2M
Balance sheet
20252024202320222021
Cash and short-term investments$232.6M$412.6M$343.9M$294.2M$119.4M
Net receivables$473.6M$409.7M$430.2M$383.1M$338.2M
Inventory$471.2M$388.1M$274M$224.3M$183.1M
Total current assets$1.26B$1.32B$1.09B$994.3M$710.3M
Property, plant and equipment, net$139.2M$213.9M$204.8M$180.8M$186.3M
Goodwill and intangible assets$1.63B$1.56B$1.88B$1.9B$1.84B
Long-term investments$0.00$31.2M$31.1M$36.7M$20.1M
Total non-current assets$2.19B$2.1B$2.23B$2.24B$2.22B
Total assets$3.46B$3.42B$3.33B$3.23B$2.93B
Accounts payable$639.8M$610.8M$426.5M$378.8M$279.3M
Short-term debt$30.8M$28.6M$24.3M$25.4M$25.1M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$829.4M$780.2M$618.3M$565.4M$459.7M
Long-term debt$1.24B$1.19B$1.14B$1.13B$1.13B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.3B$1.24B$1.29B$1.28B$1.29B
Capital lease obligations$112.5M$106.8M$85.5M$71.4M$74.5M
Total liabilities$2.13B$2.02B$1.91B$1.85B$1.75B
Common stock$20K$20K$20K$20K$20K
Retained earnings$876.9M$669.3M$457.5M$190.4M$39.9M
Accumulated other comprehensive income (loss)$4.11M$11.1M$15M$21.2M-$-450K
Total equity$1.33B$1.4B$1.42B$1.39B$1.18B
Total investments$0.00$31.2M$31.1M$36.7M$20.1M
Total debt$1.27B$1.22B$1.17B$1.16B$1.16B
Net debt$1.04B$805.4M$822.6M$860.8M$1.04B
Cash flow statement
20252024202320222021
Net income$207.6M$211.8M$267.1M$150.6M$139.9M
Depreciation and amortization$70.7M$63.5M$62.2M$65.4M$68.8M
Stock-based compensation$40M$36.1M$30.5M$16.8M$9.57M
Change in working capital-$-99.75M-$-20.25M-$-21.45M-$-29.78M-$-11.37M
Accounts receivable-$-54.59M-$-32.08M$220K-$-36.89M-$-4.27M
Inventory-$-81.47M-$-114.13M-$-51M-$-41.01M-$-22.7M
Accounts payable$19.5M$183.4M$47.7M$98.9M-$-10.38M
Net cash provided by operating activities$258.5M$323.4M$371.3M$267.6M$208.6M
Investments in property, plant and equipment-$-41.31M-$-35.61M-$-41.87M-$-35.36M-$-25.63M
Acquisitions, net-$-117.25M$0.00-$-12.49M-$-87.36M-$-85.91M
Net cash used for investing activities-$-161.08M-$-36.47M-$-56.51M-$-108.05M-$-111.54M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-309.95M-$-252.73M-$-250.26M$0.00-$-30K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-277.31M-$-218.21M-$-265.13M$15.3M-$-76.87M
Net change in cash-$-179.94M$68.7M$49.7M$174.8M$20.2M
Cash at end of period$232.6M$412.6M$343.9M$294.2M$119.4M
Operating cash flow$258.5M$323.4M$371.3M$267.6M$208.6M
Capital expenditure-$-41.31M-$-35.61M-$-41.87M-$-35.36M-$-25.63M
Free cash flow$217.1M$287.8M$329.4M$232.2M$182.9M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Option Care Health, Inc.

        Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.

        CEO
        John C. Rademacher
        Employees
        6.53K
        Beta
        0.65

        Explore

        Frequently asked questions

        What is the intrinsic value of Option Care Health, Inc. (OPCH)?

        Option Care Health, Inc. (OPCH) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is OPCH undervalued?

        OPCH trades at a price of $31.59 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.